IONQ · IonQ, Inc. · Stock research

Current Thesis

The narrative that carried this name through spring has stopped working, and the tape has confirmed it twice. The quantum gov-capital leg re-fired on the 2026-06-23 executive orders and Northland's $70 target the day before; three weeks later the stock had given back the entire move and kept going. The $44 shelf that defined the CHIPS-era breakout base broke, then $40 broke on 2026-07-13, and by 2026-07-17 the inverse quantum ETFs (IONZ, QBTZ, RGTZ) were up as much as 108% the unwind now has its own product complex. Seven consecutive down weeks, roughly 36% off the June level, more than half the October 2025 high erased.

The proximate cause is not macro alone. Wolfpack Research's February short thesis that up to 86% of 2022–2024 revenue came from Pentagon contracts Congress stopped funding has been re-priced rather than refuted, and Morgan Stanley Investment Management cutting its disclosed stake to 4.7% from roughly 7% gave it institutional validation. With a beta of 3.23 and around 103x earnings, every risk-off session (Strait of Hormuz, the oil spike, the Bitcoin drawdown) lands harder here than anywhere else in the cohort. The Q2 print, still unannounced but estimated between 2026-08-05 and 08-12, is now the referee on revenue composition rather than a growth victory lap.

Bullish and bearish views on IonQ, Inc.

The model's bull view on IonQ, Inc. (IONQ), in brief: 2026-05-06: Q1 revenue $64.67M, +755% YoY against roughly $49.7M consensus. The bear view: 2026-02-04 / re-priced July: Wolfpack's 33-page report alleged only $21M of $75.6M in 2024-booked Pentagon contracts was funded in FY2025, with the largest contract absent from the FY2026 budget for a second straight year a $54.6M revenue hole IonQ disputes. Both cases follow in full.

Bull Case

• 2026-05-06: Q1 revenue $64.67M, +755% YoY against roughly $49.7M consensus. FY2026 guide raised to $260–270M, Q2 guided $65–68M, management pointing to ~100% organic growth. The sub-scale-revenue objection is answered on the top line.
• 2026-07 (Golden Dome): IonQ secured an award under the $151B missile-defense program framework. If eligibility converts into named task orders for quantum sensing or secure communications, it directly rebuts the "lost Pentagon revenue" claim with new Pentagon revenue.
• 2026-06-23: Two executive orders on quantum computing and cybersecurity, framed around US–China competition, give the sector policy durability past the one-off May allocation.
• 2026-05-21: WSJ reported roughly $2B in awards across nine quantum names via CHIPS plus federal equity stakes, with IonQ named balance-sheet capital rather than a grant.
• 2026-06-22: Northland reiterated Outperform and raised its target to $70, now roughly 75% above the tape and untouched through the breakdown.
• 2026-07-01: Archer Materials signed a $1.5M agreement exploring an Australia-based system deployment small, but a post-print commercial datapoint.
• Sentiment is genuinely washed out after seven down weeks, which is where durable bases eventually form.

Bear Case

• 2026-02-04 / re-priced July: Wolfpack's 33-page report alleged only $21M of $75.6M in 2024-booked Pentagon contracts was funded in FY2025, with the largest contract absent from the FY2026 budget for a second straight year a $54.6M revenue hole IonQ disputes. The stock fell 28% in February and the claim resurfaced as the July catalyst.
• 2026-07 (Morgan Stanley): Stake cut to 4.7% from roughly 7%, following February's Equal-Weight and $35 target. A large holder reducing into the short thesis is the opposite of the accumulation pattern this setup requires.
• 2026-07-13: Down roughly 8% to $39.52 with QBTS, RGTI and QUBT off 6% the whole cohort broke together, so this is not an idiosyncratic dip to buy.
• 2026-07-17: Inverse quantum ETFs printing gains up to 108% confirms positioning has flipped to the short side with real vehicles behind it.
• Competition compounded: IQM's Nasdaq listing, SK hynix developments, Quantinuum public at ~$14.3B since early June, and IBM as the named White House beneficiary with a $10B commitment and 2029 roadmap. The listed pure-play scarcity premium that justified the multiple no longer exists.
• 2026-07-06: Corgi launched 24 more leveraged and buffer ETFs after 95 in June. Product proliferation at that pace marked the top, not the beginning.
• Valuation at ~103x with a 3.23 beta means the multiple compresses fastest exactly when the macro tape is worst.

Setup & Price Structure

Structure is broken, and it broke in sequence rather than in one flush. The $44 CHIPS-era shelf gave way first; the round $40 followed on 2026-07-13. The 2026-07-14 bounce attempt gained 3% premarket and still failed to reclaim the key moving averages, which is the relevant detail a rally that cannot get back above the averages it just lost is distribution, and the averages themselves are now declining resistance overhead rather than support beneath.

The next named shelf is $30, which leaves meaningful air below the current tape with no intervening structure worth defending. Seven consecutive weekly declines with no higher low anywhere in the sequence means there is nothing to anchor a risk-defined entry against. Any constructive case requires a base that does not yet exist: a higher low, a reclaim of the 20-EMA that holds on a retest, and a weekly close back above $44 to repair what was lost. Buying between the broken shelf and the untested $30 support is the position that has punished every quantum holder for seven weeks running.

Note that no live price feed exists in this build the 20-EMA, RSI(14) and the most recent swing low must be refreshed against real data before acting on any level named here.

Catalyst Calendar (next 30 days)

• ~2026-08-05 to 2026-08-12 (est., NOT confirmed): Q2 2026 results. IR had not announced the date as of 2026-07-19; analyst consensus splits between Aug 5 and Aug 12. Q1 landed 2026-05-06. Guide is $65–68M revenue. The number that matters is composition how much is government and whether the funded backlog supports the $260–270M FY guide.
• Ongoing through August: Golden Dome task-order announcements under the $151B framework. A named, dollar-sized award is the single cleanest rebuttal to the earmark thesis.
• Ongoing: Finalization of the roughly $2B CHIPS-linked quantum award list. Exclusion while peers are included would remove the last leg of the May move.
• Mid-August: 13F season. Further disclosed reductions by large holders after the Morgan Stanley cut would extend institutional confirmation of the short thesis.
• No confirmed conference appearances or product milestones inside the window.

What Would Change Our Mind

The bearish read fails if the Q2 print shows government revenue replaced by funded commercial or newly-appropriated defense backlog, and the FY $260–270M guide is held or raised. That reframes Wolfpack's hole as a transition rather than a cliff. A named Golden Dome task order with disclosed dollars before the print would do the same work faster.

On price, the repair sequence is specific: a higher low above the July trough, a reclaim of the 20-EMA that survives a retest, then a weekly close back above $44. That last level is what was lost, and until it is regained the burden of proof sits with the bulls. A second sell-side raise from anyone other than Northland, or evidence of institutional accumulation replacing the Morgan Stanley reduction, would corroborate.

What does not change the read: a bounce on cohort sympathy, a Bitcoin rally, or the $70 target that has not been revisited since the stock was 75% higher.

Correlation Notes

This trades as a high-beta risk proxy first and a quantum-computing company second. The 2026-06-24 and 2026-07-13 sessions both saw it move with Bitcoin and broad risk appetite, not with anything quantum-specific the Strait of Hormuz oil spike was the proximate driver of the July 13 break.

Within the cohort, correlation to QBTS, RGTI and QUBT is near-total on directional days (all four moved together on 2026-07-13), so exposure across quantum names is one position, not several. The gov-capital theme links it to the broader CHIPS and defense-appropriation complex, where IBM is now the better-capitalized beneficiary. The QTUM ETF near $5B AUM and the leveraged and inverse product stack mean flows into and out of the theme now hit every constituent mechanically, amplifying moves in both directions and making single-name analysis less predictive than it was six months ago.